Literature DB >> 7889889

Toxicity and carcinogenicity studies of boric acid in male and female B6C3F1 mice.

M P Dieter1.   

Abstract

Toxicity and potential carcinogenicity studies of boric acid were investigated in mice to verify in a second rodent species that this was a noncarcinogenic chemical. Earlier chronic studies in rats indicated boric acid was not a carcinogen. The chemical is nominated for testing because over 200 tons are produced annually, there are multiple uses for the product, and there is potential for widespread human exposure, both orally and dermally. Both sexes of B6C3F1 mice were offered diets mixed with boric acid for 14 days, 13 weeks, or 2 years. Dietary doses used in the acute, 14-day study were 0, 0.62, 1.25, 2.5, 5, and 10%; those in the subchronic, 13-week study were 0, 0.12, 0.25, 0.50, 1, and 2%; and doses in the 2-year, chronic study were 0, 0.25, and 0.50% in the diet. Mortality, clinical signs of toxicity, estimates of food consumption, body weight gain, and histopathologic examination of selected tissues constituted the variables measured. In the 14-day study mortality was proportional to dose and time of exposure in both sexes, occurring in dose groups as low as 2.5% and as early as 7 days of exposure. Body weights were depressed more than 10% below controls in the higher dose groups of both sexes. Mortality in the 13-week study was confined to the two highest dose groups in male mice and to the 2%-dose group in females. Body weight depression from 8 to 23% below those of controls occurred in the 0.50% and higher dose groups of both sexes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889889      PMCID: PMC1566652          DOI: 10.1289/ehp.94102s793

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  10 in total

1.  The urinary excretion of boric acid preparations following oral administration and topical applications to intact and damaged skin of rabbits.

Authors:  J H DRAIZE; E A KELLEY
Journal:  Toxicol Appl Pharmacol       Date:  1959-05       Impact factor: 4.219

2.  Inabsorbability of boric acid in infant powder.

Authors:  A J VIGNEC; R ELLIS
Journal:  AMA Am J Dis Child       Date:  1954-07

3.  The toxicity of boric acid and the clinical implications of the use of borated baby powders.

Authors:  M G MULINOS; C CONNANT; E HAUSER
Journal:  Bulletin NY Med Coll       Date:  1953

4.  Boric acid poisoning; report of four cases and a review of 109 cases from the world literature.

Authors:  R B GOLDBLOOM; A GOLDBLOOM
Journal:  J Pediatr       Date:  1953-12       Impact factor: 4.406

5.  Boric acid treatment of vulvovaginal candidiasis.

Authors:  T E Swate; J C Weed
Journal:  Obstet Gynecol       Date:  1974-06       Impact factor: 7.661

6.  Toxicologic studies on borax and boric acid.

Authors:  R J Weir; R S Fisher
Journal:  Toxicol Appl Pharmacol       Date:  1972-11       Impact factor: 4.219

7.  [Toxicity of boric acid].

Authors:  R Schuppli; H Seiler; R Schneeberger; H Niggli; K Hoffmann
Journal:  Dermatologica       Date:  1971

8.  Salmonella mutagenicity test results for 250 chemicals.

Authors:  S Haworth; T Lawlor; K Mortelmans; W Speck; E Zeiger
Journal:  Environ Mutagen       Date:  1983

9.  Toxic and gonadotropic effects of cadmium and boron relative to standards for these substances in drinking water.

Authors:  G N Krasovskii; S P Varshavskaya; A I Borisov
Journal:  Environ Health Perspect       Date:  1976-02       Impact factor: 9.031

10.  Statistical issues in the design, analysis and interpretation of animal carcinogenicity studies.

Authors:  J K Haseman
Journal:  Environ Health Perspect       Date:  1984-12       Impact factor: 9.031

  10 in total
  1 in total

1.  Toxic effects of excess exposure to boric acid on serum biochemical aspect, hematology and histological alterations and ameliorative potential role of melatonin in rats.

Authors:  Hager Tarek H Ismail
Journal:  Saudi J Biol Sci       Date:  2022-08-22       Impact factor: 4.052

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.